Loading clinical trials...
Loading clinical trials...
This is a Phase 1b, open-label, multicenter, safety, tolerability and efficacy study of HC-7366 in combination with belzutifan (WELIREG™). This is a multipart study that consists of a HC-7366 monother...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
HiberCell, Inc.
Collaborators
NCT07645690 · Unresectable or Metastatic Clear Cell Renal Cell Carcinoma
NCT06661720 · Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and more
NCT06863311 · Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, and more
NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more
NCT04659343 · Kidney Cancer, Renal Cell Carcinoma Metastatic, and more
University of Arizona Cancer Center
Tucson, Arizona
University of California San Diego Moores Cancer Center
La Jolla, California
Cedars-Sinai Medical Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions